Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,893.50
-19.50 (-0.67%)
Oct 21, 2026, 3:30 PM JST
Rohto Pharmaceutical Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Rohto Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥3,290. The average 1-year stock price forecast is 13.70% higher than the current stock price, while the lowest is ¥2,600 (-10.14%) and the highest is ¥3,840 (+32.71%).
Price Target: ¥3,290 (+13.70%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 14, 2026.
Analyst Ratings
The average analyst rating for Rohto Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Sep 25, 2026 |
| Jefferies | Jefferies | Buy Maintains ¥2,950 | Buy | Maintains | ¥2,950 | +1.95% | Jul 14, 2026 |
Financial Forecast
Revenue This Year
375.14B
from 343.73B
Increased by 9.14%
Revenue Next Year
389.31B
from 375.14B
Increased by 3.78%
EPS This Year
162.29
from 145.29
Increased by 11.70%
EPS Next Year
170.56
from 162.29
Increased by 5.09%
Financial currency is JPY.